These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4581915)

  • 61. [Reduced immunologic reactivity in patients with malignant hematologic diseases and tumors].
    Libánský J
    Vnitr Lek; 1978 May; 24(5):469-74. PubMed ID: 664375
    [No Abstract]   [Full Text] [Related]  

  • 62. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 64. [Cellular immunity indices in lymphogranulomatosis].
    Baĭsogolov GD; Pavlov VV; Konopliannikov AG; Kozlov VM; Kulish IuS
    Sov Med; 1981; (6):29-34. PubMed ID: 6974405
    [No Abstract]   [Full Text] [Related]  

  • 65. The effects of MP virus infection in lymphoma.
    Horton J; Hotchin JE; Olson KB; Davies JN
    Cancer Res; 1971 Aug; 31(8):1066-8. PubMed ID: 4999485
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
    Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG].
    Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C
    Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736
    [No Abstract]   [Full Text] [Related]  

  • 68. Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
    Hindy I; Sellei C; Eckhardt S; Szentklãray J; Hartai F
    Neoplasma; 1971; 18(3):277-82. PubMed ID: 4937513
    [No Abstract]   [Full Text] [Related]  

  • 69. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 70. [Cellular immunity in patients with malignant lymphoma].
    Klára S; Endre K; Tibor C
    Orv Hetil; 1976 Jul; 117(30):1811-4. PubMed ID: 940666
    [No Abstract]   [Full Text] [Related]  

  • 71. [Levels of immunoglobulins, heteroagglutinins and delayed hypersensitivity reactions in children with acute lymphoblastic leukemia (ALL)].
    Janković MB; Vuković I
    Srp Arh Celok Lek; 1984; 112(7-8):777-84. PubMed ID: 6596726
    [No Abstract]   [Full Text] [Related]  

  • 72. [The immune response to tetanus toxoid in neoplasms].
    Purice S; Drăgoi T; Dăncescu I
    Stud Cercet Med Interna; 1969; 10(4):335-42. PubMed ID: 4905682
    [No Abstract]   [Full Text] [Related]  

  • 73. [Immunity in cases of neoplasms treated with cytostatic drugs].
    Lotreanu V; Sarafoleanu D
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):59-60. PubMed ID: 6454220
    [No Abstract]   [Full Text] [Related]  

  • 74. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [DNA antibodies in patients with malignant neoplasms with varying localization].
    Stefani NV; Saenko NT; Poverennyĭ AM
    Vopr Onkol; 1973; 19(12):34-7. PubMed ID: 4595157
    [No Abstract]   [Full Text] [Related]  

  • 76. Protein production. A possible unifying concept of reticuloendothelial disease.
    King FM
    Natl Cancer Inst Monogr; 1969 Aug; 32():313-4. PubMed ID: 4187008
    [No Abstract]   [Full Text] [Related]  

  • 77. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 78. Immunoglobulin levels in children treated for malignant tumors.
    Eckschlager T; Honzová S
    Neoplasma; 1993; 40(6):347-50. PubMed ID: 8289965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The development and involution of the lymphoid system and immunologic capacity.
    Good RA; Finstad J
    Trans Am Clin Climatol Assoc; 1968; 79():69-107. PubMed ID: 4875361
    [No Abstract]   [Full Text] [Related]  

  • 80. [Study of tuberculin allergy in patients with lymphogranulomatosis].
    Veskova TK; Unukova EN
    Probl Gematol Pereliv Krovi; 1974 Mar; 19(3):21-4. PubMed ID: 4831501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.